Tiwari Arvind Kumar, Kumar Subodh, Pal Vijai, Bhardwaj Bhupendra, Rai Ganga Prasad
Division of High Containment Facility, Defence Research and Development Establishment, Jhansi Road, Gwalior-474 002, India.
Clin Vaccine Immunol. 2011 Oct;18(10):1760-4. doi: 10.1128/CVI.05159-11. Epub 2011 Aug 18.
Brucellosis is a disease with worldwide distribution affecting animals and human beings. Brucella abortus is the causative agent of bovine brucellosis. The cross-reactions of currently available diagnostic procedures for B. abortus infection result in false-positive reactions, which make the procedures unreliable. These tests are also unable to differentiate Brucella-infected and -vaccinated animals. The present work is focused on the use of a nonlipopolysaccharide (LPS) diagnostic antigen, a recombinant 10-kDa (r10-kDa) protein of B. abortus, for specific diagnosis of brucellosis. The purified recombinant protein was used as a diagnostic antigen in plate enzyme-linked immunosorbent assay (p-ELISA) format to screen 408 bovine serum samples (70 presumptively negative, 308 random, and 30 vaccinated), and the results were compared with those of the Rose Bengal plate agglutination test (RBPT) and the standard tube agglutination test (STAT). Statistical analysis in presumptive negative samples revealed 100 and 98.41% specificity of p-ELISA with RBPT and STAT, and an agreement of 91.43% with the tests using Cohen's kappa statistics. In random samples, the agreement of p-ELISA was 77.92% and 80.52% with RBPT and STAT, respectively. p-ELISA investigation of vaccinated samples reported no false-positive results, whereas RBPT and STAT reported 30% and 96.6% false-positive results, respectively. The data suggest that p-ELISA with r10-kDa protein may be a useful method for diagnosis of bovine brucellosis. Furthermore, p-ELISA may also be used as a tool for differentiating Brucella-vaccinated and naturally infected animals.
布鲁氏菌病是一种在全球范围内分布的疾病,可感染动物和人类。流产布鲁氏菌是牛布鲁氏菌病的病原体。目前用于检测流产布鲁氏菌感染的诊断方法存在交叉反应,会导致假阳性结果,使得这些方法不可靠。这些检测也无法区分感染布鲁氏菌和接种过疫苗的动物。目前的工作重点是使用一种非脂多糖(LPS)诊断抗原,即流产布鲁氏菌的重组10 kDa(r10-kDa)蛋白,用于布鲁氏菌病的特异性诊断。将纯化的重组蛋白用作平板酶联免疫吸附测定(p-ELISA)形式的诊断抗原,以筛查408份牛血清样本(70份推定阴性、308份随机样本和30份接种过疫苗的样本),并将结果与玫瑰红平板凝集试验(RBPT)和标准试管凝集试验(STAT)的结果进行比较。对推定阴性样本的统计分析显示,p-ELISA与RBPT和STAT相比,特异性分别为100%和98.41%,使用科恩kappa统计量与这些检测的一致性为91.43%。在随机样本中,p-ELISA与RBPT和STAT的一致性分别为77.92%和80.52%。对接种过疫苗的样本进行p-ELISA检测未报告假阳性结果,而RBPT和STAT分别报告了30%和96.6%的假阳性结果。数据表明,使用r10-kDa蛋白的p-ELISA可能是诊断牛布鲁氏菌病的一种有用方法。此外,p-ELISA也可作为区分接种布鲁氏菌疫苗和自然感染动物的工具。